Hyungjun Yang

Hyungjun Yang

Auto-generated profile, based on publicly available information

Hyungjun Yang

University of British Columbia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2025 in Gut Microbes
Verified
Journal Article
Open access
MJMaira Jimenez-Sanchez
Maira Jimenez-Sanchez
LCLarissa Celiberto
Larissa Celiberto
HYHyungjun Yang
Hyungjun Yang
HSHo Pan Sham
Ho Pan Sham
BVBruce A Vallance
Bruce A Vallance
This review explores the emerging term "gut-skin axis" (GSA), describing the bidirectional signaling that occurs between the skin and the gastrointestinal tract under both homeostatic and disease conditions. Central to GSA communication are the gut and skin microbiota, the microbial communities that colonize these barrier surfaces. By influencing diverse host pathways, including innate immune, vitamin D receptor, and Aryl hydrocarbon receptor signaling, a balanced microbiota contributes to both tissue homeostasis and host defense. In contrast, microbiota imbalance, or dysbiosis at one site, can lead to local barrier dysfunction, resulting in the activation of signaling pathways that can disrupt tissue homeostasis at the other site, potentially leading to inflammatory skin conditions such as atopic dermatitis and psoriasis, or gut diseases like Inflammatory Bowel Disease. To date, most research on the GSA has examined the impact of the gut microbiota and diet on skin health, but recent studies show that exposing the skin to ultraviolet B-light can beneficially modulate both the gut microbiome and intestinal health. Thus, despite the traditional focus of clinicians and researchers on these organ systems as distinct, the GSA offers new opportunities to better understand the pathogenesis of cutaneous and gastrointestinal diseases and promote health at both sites.

20 March 2019 in Cellular Microbiology
Verified
Journal Article
Closed access
PDF file
HYHyungjun Yang
Hyungjun Yang
HYHong B. Yu
Hong B. Yu
GBGanive Bhinder
Ganive Bhinder
NRNatasha R. Ryz
Natasha R. Ryz
JLJulia Lee
Julia Lee
BVBruce A Vallance
Bruce A Vallance

10 June 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JAJae-Hee Ahn
Jae-Hee Ahn
JCJaewon Cho
Jaewon Cho
BKBo-Eun Kwon
Bo-Eun Kwon
GLGeun-Shik Lee
Geun-Shik Lee
SYSung-Il Yoon
Sung-Il Yoon
HKHyun-Jeong Ko
Hyun-Jeong Ko
Inhibitor of kappa B (IκB)-ζ transcription is rapidly induced by stimulation with TLR ligands and IL-1. Despite high IκBζ expression in inflammation sites, the association of IκBζ with host defence via systemic immune responses against bacterial infection remains unclear. Oral immunisation with a recombinant attenuated Salmonella vaccine (RASV) strain did not protect IκBζ-deficient mice against a lethal Salmonella challenge. IκBζ-deficient mice failed to produce Salmonella LPS-specific IgG, especially IgG2a, although inflammatory cytokine production and immune cell infiltration into the liver increased after oral RASV administration. Moreover, IκBζ-deficient mice exhibited enhanced splenic germinal centre reactions followed by increased total IgG production, despite IκBζ-deficient B cells having an intrinsic antibody class switching defect. IκBζ-deficient CD4+ T cells poorly differentiated into Th1 cells. IFN-γ production by CD4+ T cells from IκBζ-deficient mice immunised with RASV significantly decreased after restimulation with heat-killed RASV in vitro, suggesting that IκBζ-deficient mice failed to mount protective immune responses against Salmonella infection because of insufficient Th1 and IgG production. Therefore, IκBζ is crucial in protecting against Salmonella infection by inducing Th1 differentiation followed by IgG production.

5 May 2025 in Gut Microbes
Verified
Journal Article
Open access
YCYan Chen
Yan Chen
AGAshley Gilliland
Ashley Gilliland
QLQiaochu Liang
Qiaochu Liang
XHXiao Han
Xiao Han
HYHyungjun Yang
Hyungjun Yang
BVBruce A Vallance
Bruce A Vallance
Enteric bacterial pathogens pose significant threats to human health; however, the mechanisms by which they infect the mammalian gut in the face of daunting host defenses remain to be fully defined. For the attaching and effacing (A/E) bacterial family member and murine pathogen Citrobacter rodentium, its virulence strategy appears to involve penetration of the colonic mucus barrier to reach the underlying epithelium. To better define these interactions, we grew colonoids under air-liquid interface (ALI) conditions, producing a thick mucus layer that mimicked in vivo mucus composition and glycosylation. C. rodentium's penetration of ALI-derived mucus was dramatically enhanced upon exposure to sialic acid, in concert with the secretion of two serine protease autotransporter of Enterobacteriaceae (SPATE) proteins, Pic and EspC. Despite Pic being a class II SPATE, and already recognized as a mucinase, it was EspC, a class I SPATE family member, that degraded ALI-derived mucus, despite class I SPATEs not previously shown to possess mucinase activity. Confirming this finding, E. coli DH5α carrying a plasmid that expresses C. rodentium-derived EspC was able to degrade the mucus. Moreover, recombinant EspC alone also displayed mucinolytic activity in a dose-dependent manner. Collectively, our results reveal the utility of ALI-derived mucus in modeling microbe-host interactions at the intestinal mucosal surface, as well as identify EspC as an atypical class I SPATE that shows significant mucinolytic activity toward ALI-derived mucus.

9 January 2025 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
SKSrinivas Kantham
Srinivas Kantham
HYHongbing Yu
Hongbing Yu
CCChristophe R. Cantelli
Christophe R. Cantelli
GCGang Chen
Gang Chen
CMCaixia Ma
Caixia Ma
RYRobert N. Young
Robert N. Young

15 April 2026 in Infection and Immunity
Verified
Journal Article
Open access
ZHZhiquan Clarence Huang
Zhiquan Clarence Huang
MMMatthias Ahmad Mslati
Matthias Ahmad Mslati
CMCaixia Ma
Caixia Ma
HYHyungjun Yang
Hyungjun Yang
QLQiaochu Liang
Qiaochu Liang
BVBruce A Vallance
Bruce A Vallance
Many enteric bacterial pathogens, including attaching/effacing (A/E) Escherichia coli strains, cause acute gastroenteritis in humans. Considering the highly competitive nature of the mammalian gastrointestinal (GI) tract, these pathogens must rely on specific metabolic adaptations to establish successful infections. We hypothesized that A/E pathogens exploit host-derived nutrients within GI mucus, including N-acetylglucosamine (GlcNAc) and N-acetylneuraminic acid (NeuNAc), to fuel their pathogenesis. To address this hypothesis, we disrupted both GlcNAc and NeuNAc metabolic pathways in Citrobacter rodentium, a murine-specific A/E pathogen, by deleting nagA , which encodes the GlcNAc-6-phosphate (GlcNAc-6P) deacetylase that converts GlcNAc-6P into glucosamine-6-phosphate (GlcN-6P). Compared to wild-type (WT) C. rodentium , the Δ nagA mutant showed severely attenuated colonization and pathogenesis in C57BL/6J mice. Although Δ nagA cannot catabolize GlcNAc and NeuNAc, its in vivo defect could not be explained by nutrient deprivation alone. Instead, Δ nagA exhibited higher levels of cytosolic GlcNAc-6P, slower growth rate when cultured in vitro , altered regulation of GlcN-6P synthesis, and increased susceptibility to cell wall-targeting stressors. Supplementation with glucosamine (GlcN, which can be directly converted into GlcN-6P) partially restored the growth and resistance to cell wall stress of Δ nagA without reducing GlcNAc-6P accumulation, indicating that dysregulated GlcN-6P synthesis rather than GlcNAc-6P toxicity underlies its phenotype. Together, these data reveal a previously unrecognized metabolic vulnerability in C. rodentium where the disruption of the GlcNAc and NeuNAc metabolic pathways, by inactivating NagA, creates a sugar-phosphate imbalance that compromises cell wall integrity and pathogen fitness. Hence, targeting sugar-phosphate stress responses may provide a new therapeutic strategy against GI bacterial pathogens.